Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
chlormidazole
- Development stage
- Unknown
- Lead developer
- Grünenthal
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Chlormidazole is a synthetic antifungal agent belonging to the benzimidazole class of organic compounds. It contains a benzene ring fused to an imidazole ring and is classified under ATC code D01AC04. Chlormidazole acts as an antifungal by interfering with fungal cell processes, though its precise mechanism of action is not detailed in the available sources. It is structurally related to other imidazoles and benzimidazoles, which are known for their activity against fungal infections[2].
Beyond the preview
Go deeper on chlormidazole.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on chlormidazole.